Brazzell Romulus K
SEC CIK 1298079 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | SEE REMARKS | 36.0K | — | $173.9K | 17 | 2021-10-26 | 2025-10-22 |
Most active insiders at KALA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BAKER JULIAN | Former 10% owner | — | $1.06M |
| 2 | Iwicki Mark T | Dir | — | $125.5K |
| 3 | Bazemore Todd | Dir | — | $39.6K |
| 4 | Brazzell Romulus K | SEE REMARKS | — | $38.8K |
| 5 | Reumuth Mary | CFO | — | $27.5K |
| 6 | Kharabi Darius | Chief BUSINESS Off | — | $17.3K |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-24 | 2025-10-22 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $0.83 | -46.7K | 36.0K | -57% | -$38.8K | |
| 2025-06-26 | 2025-06-24 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $4.01 | -5,251 | 82.7K | -6% | -$21.1K | |
| 2025-06-04 | 2025-06-03 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $3.74 | -3,687 | 87.9K | -4% | -$13.8K | |
| D | 2025-01-07 | 2025-01-06 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | A - Grant | $0.00 | +10.1K | 94.9K | +12% | $0 |
| D | 2025-01-07 | 2025-01-06 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $7.63 | -2,446 | 92.4K | -3% | -$18.7K |
| 2024-06-27 | 2024-06-26 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $4.75 | -5,489 | 84.0K | -6% | -$26.1K | |
| 2024-06-03 | 2024-05-31 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $6.09 | -2,002 | 89.5K | -2% | -$12.2K | |
| D | 2024-01-05 | 2024-01-04 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | A - Grant | $0.00 | +6,500 | 93.1K | +8% | $0 |
| D | 2024-01-05 | 2024-01-04 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $6.74 | -1,617 | 91.5K | -2% | -$10.9K |
| D | 2023-06-23 | 2023-06-22 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | A - Grant | $0.00 | +49.4K | 85.8K | +135% | $0 |
| D | 2023-06-02 | 2023-05-31 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | A - Grant | — | +17.9K | 36.5K | +97% | — |
| 2023-01-06 | 2023-01-04 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $28.53 | -73 | 18.5K | -0.4% | -$2,083 | |
| 2023-01-06 | 2023-01-04 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | A - Grant | $0.00 | +12.8K | 18.6K | +220% | $0 | |
| 2022-10-28 | 2022-10-26 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $6.51 | -261 | 5,809 | -4% | -$1,699 | |
| 2022-06-29 | 2022-06-27 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $0.37 | -3,144 | 285.2K | -1% | -$1,163 | |
| D | 2022-01-05 | 2022-01-04 | KALA | KALA BIO, Inc. | Brazzell Romulus K | SEE REMARKS | S - Sale | $1.30 | -3,504 | 288.3K | -1% | -$4,555 |
| 2021-10-28 | 2021-10-26 | KALA | KALA BIO, Inc. | Brazzell Romulus K | Chief MEDICAL Off | S - Sale | $1.80 | -12.8K | 291.8K | -4% | -$23.0K |
Purchase Sale Sale after option exercise All abbreviations